‹ All Posts
Ankit Gupta

13th Jan · SEBI-Registered Analyst

ZYDUSLIFE
LIFESCIENCES: FDA APPROVES ZYCUBO® (COPPER HISTIDINATE) FOR MENKES DISEASE TREATMENT; FIRST AND ONLY THERAPY APPROVED IN THE U.S.; SIGNIFICANT IMPROVEMENT IN OVERALL SURVIVAL DEMONSTRATED

#StockInNews#Miscellaneous#EquityResearch
1,061 likes·56 comments